JAKAB LEVELE 1:13-14

JAKAB LEVELE 1:13-14 CSIA

Senki, ha kísértetik, ne mondja: Isten kísért engem. Mert Istenig nem hat el a gonoszok kísértése. Ő maga pedig senkit sem kísért. Ellenkezőleg, mindenkit saját vágya kísért, mely őt húzza, csalogatja.

Read JAKAB LEVELE 1

Compare All Versions: JAKAB LEVELE 1:13-14

Verse Images for JAKAB LEVELE 1:13-14

JAKAB LEVELE 1:13-14 - Senki, ha kísértetik, ne mondja: Isten kísért engem. Mert Istenig nem hat el a gonoszok kísértése. Ő maga pedig senkit sem kísért.
Ellenkezőleg, mindenkit saját vágya kísért, mely őt húzza, csalogatja.

Free Reading Plans and Devotionals related to JAKAB LEVELE 1:13-14

The Reflective Christian

3 Days

The Reflective Christian is intended to spark in the reader a desire/habit of loving the Lord with the mind. Christians ought to learn to constantly look at the reality around us through the lens of the Bible. This exercise paves way to transform our mind to gradually conform to the mind of Christ, as we train to reflect on the mundane and the monotonous everyday occurrences in the light of God’s active and unchanging word

The Wisdom of Humility

3 Days

Are you humble? Do you struggle with humility? Why is humility important? These are the questions this series tries to answer.

Being Filled With God's Love

3 Days

Do you ever feel dry, empty, and parched as though you have nothing left to give? The theme of these guided audio meditations is about being filled and quenched by God. Day 1 is about having a heart filled with the hope of God. Day 2 will help you learn to be filled with what is real. And Day 3 is about being filled with the love of God.

Golden Repair

3 Days

Life breaks us all so says Earnest Hemingway, but many are made stronger at the broken places. We will journey together through things in life that can break us and what God does in our brokenness to strengthen us and to bring beauty and joy out of our broken places. We will see what James tells us is the reality of trials, the response we are to have and the result of our response to those trials.